 A jury in the U.S. District Court for the District of Delaware rendered a verdict that Illumina Inc NASDAQ: ILMN willfully infringed the U.S. Patent Nos. 9,222,132 and 10,662,473 owned by Complete Genomics Inc. The jury awarded approximately 334 million to CGI in past. 